You are here: Industry Insights > Translate Bio

News List

Sanofi offers to buy U.S. mRNA partner Translate Bio firstwordpharma
August 03, 2021
Two sources familiar with the situation said Monday that Sanofi has offered to buy Translate Bio as the French drugmaker bets on next-generation mRNA technology following setbacks in the COVID-19 vaccine race, as reported in This is Money.
Translate Bio, Sanofi Covid-19 vaccine elicits immune response in animals pharmaceutical-technology
August 26, 2020
Translate Bio has reported that its Covid-19 vaccine candidate, being developed in collaboration with Sanofi, elicited immune response in early-stage animal studies.
Sanofi and Translate Bio Expand Vaccine Collaboration contractpharma
June 28, 2020
To develop mRNA vaccines across all infectious disease areas in a deal potentially worth up to $1.9 billion.
Sanofi and Translate Bio team up to develop mRNA vaccines pharmaceutical-technology
June 24, 2020
Sanofi vaccines business unit Sanofi Pasteur has expanded its existing 2018 partnership with messenger RNA (mRNA) therapeutics firm Translate Bio for the development of mRNA vaccines against various infectious diseases.
Sanofi, Translate Bio to develop novel mRNA vaccine for COVID-19 disease pharmaceutical-business-review
March 31, 2020
Sanofi’s vaccines global business unit Sanofi Pasteur has collaborated with Translate Bio for the development of a novel messenger RNA (mRNA) vaccine for COVID-19, the disease resulted due to the novel coronavirus SARS-CoV-2.
Sanofi and Translate Bio to develop mRNA vaccine for Covid-19 pharmaceutical-technology
March 30, 2020
Sanofi vaccines division Sanofi Pasteur has partnered with Translate Bio for the development of a messenger RNA (mRNA) vaccine against Covid-19.
Sanofi, Translate Bio ink mRNA vaccine R&D deal worth up to $805M fiercevaccines
June 26, 2018
Moving to expand its vaccine pipeline after some slip-ups last year, Sanofi is betting on Translate Bio's mRNA platform in up to five undisclosed infectious disease targets.
Sanofi Pasteur and Translate Bio to develop new mRNA vaccines pharmaceutical-technology
June 13, 2018
Global vaccine company Sanofi Pasteur has signed a research and development (R&D) collaboration and exclusive licensing agreement with therapeutics company Translate Bio to develop new vaccines using mRNA technology.
Translate Bio Announces FDA Clearance to Proceed with Phase 1/2 Clinical Trial in Patients with Cystic Fibrosis (CF) biospace
April 13, 2018
Translate Bio today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company to begin a first-in-human clinical trial of MRT5005 in patients with cystic fibrosis